HSPA5 and cancer: Down-regulation of Grp78/Bip expression could be achieved using the cancer drug OSU-03012, developed from Celecoxib, that supresses Grp78/Bip expression by > 90% in many tumour cell lines and significantly increases tumor cell killing [73].